Literature DB >> 32839883

Neuronal intranuclear inclusion disease: two case report and literature review.

Xiang Qin1, Hao Chen2, Chenguang Zhou3, XiaoLong Wang1, Jingjing Gao1, Nan Guo1, Yujing Wang2, Shaodong Li4.   

Abstract

Neuronal intranuclear inclusion disease (NIID) is a rare and slowly progressing neurodegenerative disease characterized by the presence of eosinophilic intranuclear inclusions in the nervous system and multiple visceral organs. Sporadic NIID case was more frequently encountered than familial. In our study, we reported two adult-onset NIID patients from a family and described their clinical, imaging, and pathological features. The first patient was a 61-year-old man who only presented with non-specific headache and dizziness; however, Brain MRI with diffusion-weighted images (DWI) sequence showed high-intensity signal involving a small regional portion of corticomedullary junction in the frontal and parietal lobe. The older sister of former, a 64-year-old female, who developed sudden onset of weakness of the right limb was admitted to our neurology department. Compared with the first patient, similar DWI high-intensity signal but more extensive area in the corticomedullary junction was found in her brain MRI examination, also prominent leukoencephalopathy in T2-weighted image. Significantly, skin pathology of the first patient showed that typical inclusions with strongly positive P62 and ubiquitin antibody could be seen in the nuclei of sweat gland cells, adipocytes, and fibroblasts. FMR1 gene was negative. Although rare, adult-onset NIID should be considered when the characteristic radiology changes of high intensity signal involving the corticomedullary junction in the brain DWI sequence was found. In addition, the pathological result of skin biopsy combined with negative genetic testing FMR1 or NOTCH2NLC can contribute to the accurate diagnosis of the disease. This article aims to improve the radiologists' knowledge of NIID by our cases presentation and reviewing literature.

Entities:  

Keywords:  Neuronal intranuclear inclusion disease

Mesh:

Substances:

Year:  2020        PMID: 32839883     DOI: 10.1007/s10072-020-04613-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  1 in total

1.  [Neuronal Intranuclear Inclusion Disease].

Authors:  Jun Sone; Gen Sobue
Journal:  Brain Nerve       Date:  2017-01
  1 in total
  3 in total

Review 1.  Neuronal intranuclear inclusion disease: recognition and update.

Authors:  Xi Lu; Daojun Hong
Journal:  J Neural Transm (Vienna)       Date:  2021-02-18       Impact factor: 3.575

Review 2.  NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders.

Authors:  Lanxiao Cao; Yaping Yan; Guohua Zhao
Journal:  Neurol Sci       Date:  2021-08-01       Impact factor: 3.307

Review 3.  Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Authors:  Yueqi Liu; Hao Li; Xuan Liu; Bin Wang; Hao Yang; Bo Wan; Miao Sun; Xingshun Xu
Journal:  Front Aging Neurosci       Date:  2022-09-13       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.